DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
van den Bent MJ, Baumert B, Erridge SC. et al.
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
Lancet 2017;
390 (10/103) 1645-1653
We do not assume any responsibility for the contents of the web pages of other providers.